Eligibility of patients with type 2 diabetes for sodium-glucose co-transporter-2 inhibitor cardiovascular outcomes trials: An assessment using the Diabetes Collaborative Registry

Topics: 

Citation
Wittbrodt E, et al. Diabetes Obes Metab 2019.21(8):1985-1989.